Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,712 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,712 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,712 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,712 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,712 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,712 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,712 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Mar 2026
Christian Follmann Chief Operating Officer
Sold at will
$73.40K 5,000 at 14.68
3.2%
Not planned
4 Mar 2026
Mukund Paravasthu Chief Operating Officer
Sold at will
$71.54K 5,377 at 13.31
4.4%
Not planned
4 Mar 2026
Mattias Stetz Chief Operating Officer
Sold on a plan
$68.71K 3,398 at 20.22
1.3%
Planned (10b5-1)
4 Mar 2026
Ryan J. Long EVP, Chief Legal and
Sold at will
$66.33K 800 at 82.91
3.9%
Not planned
4 Mar 2026
Torran B Nixon Senior Executive VP
Sold on a plan
$64.62K 2,240 at 28.85
2.2%
Planned (10b5-1)
4 Mar 2026
Lindsay Ellis See Remarks
Sold at will
$59.12K 1,260 at 46.92
2.6%
Not planned
4 Mar 2026
Kelly Hutcheson EVP/Chief Accounting Officer
Sold at will
$52.18K 1,350 at 38.65
7.5%
Not planned
4 Mar 2026
Neil Fryer VP and GM Global Aftermarket
Sold at will
$45.39K 624 at 72.75
3.3%
Not planned
4 Mar 2026
Effie D Silva SVP, General Counsel & Secy
Sold at will 2×
$45.32K 1,072 at 42.28
6.9%
Not planned
4 Mar 2026
Ramiro Ribeiro Chief Medical Officer
Sold on a plan
$43.57K 2,438 at 17.87
100%
Sold half or more
4 Mar 2026
Peter McNamara Chief Scientific Officer
Sold on a plan
$41.25K 1,650 at 25.00
2.7%
Planned (10b5-1)
4 Mar 2026
Joseph Baroldi EVP, Chief Business Officer · indirect
Sold on a plan 2×
$35.12K 439 at 80.00
9.2%
Planned (10b5-1)
4 Mar 2026
Danny Dumas SVP, NA Sales, Mkt & Prd Mgmt
Sold at will 2×
$34.59K 818 at 42.28
24.2%
Not planned
4 Mar 2026
Leena Mansharamani SVP, Chief Accounting Officer
Sold at will
$34.42K 1,926 at 17.87
3.1%
Not planned
4 Mar 2026
Sold at will
$31.37K 11,663 at 2.69
8.2%
Not planned
4 Mar 2026
Jeannette Potts Chief Legal Officer
Sold at will
$30.91K 3,412 at 9.06
2.4%
Not planned
4 Mar 2026
Cathy A King CLO & Corporate Secretary
Sold on a plan
$27.72K 1,517 at 18.27
2.6%
Planned (10b5-1)
4 Mar 2026
Kevin Maddock EVP,ChiefRecurringRev.Officer also filed by David W. Rowe
Sold at will 2×
$26.26K 7,209 at 3.64
3.8%
Not planned
4 Mar 2026
Ziad Nabulsi SVP, North American Operations
Sold at will 2×
$26.04K 616 at 42.28
3.8%
Not planned
4 Mar 2026
Tyrone Graham EVP, Chief HR Officer
Sold on a plan
$19.48K 501 at 38.88
3.1%
Planned (10b5-1)
4 Mar 2026
Nancy Lyskawa EVP & Chief Client Officer
Sold at will 2×
$19.44K 5,337 at 3.64
2.6%
Not planned
4 Mar 2026
Steven Hershkowitz EVP & Chief Revenue Officer
Sold at will 2×
$18.92K 5,193 at 3.64
4.6%
Not planned
4 Mar 2026
Sold at will
$18.15K 1,405 at 12.92
2.1%
Not planned
4 Mar 2026
Nathan B. Theurer VP - Global Controller and CAO
Sold on a plan
$18.12K 92 at 196.95
100%
Sold half or more
4 Mar 2026
Aviva McPherron Pres, Global Ops & Qual
Sold at will
$16.74K 1,296 at 12.92
1.8%
Not planned
4 Mar 2026
Robert Lorne Abel See Remarks
Sold on a plan
$16.65K 1,300 at 12.81
2.3%
Planned (10b5-1)
4 Mar 2026
Lucas Vitale Cp&Boo
Sold at will
$15.12K 1,171 at 12.92
0.7%
Not planned
4 Mar 2026
Michal Nath Puri Chief Human Resources Officer also filed by Nicolas Leupin
Sold at will
$14.64K 1,100 at 13.31
0.5%
Not planned
4 Mar 2026
Max Reinhardt President, Global Spine
Sold at will
$13.95K 1,080 at 12.92
3.9%
Not planned
4 Mar 2026
Bret T Jardine Chief Legal Officer
Sold on a plan
$13.43K 1,090 at 12.32
13.5%
Planned (10b5-1)
4 Mar 2026
Reuven Spiegel Executive Vice President, DKL
Sold on a plan
$13.30K 250 at 53.20
1.1%
Planned (10b5-1)
4 Mar 2026
Paul Streck EVP, Head of R&D
Sold at will 2×
$11.71K 1,879 at 6.23
2.4%
Not planned
4 Mar 2026
Hamid Khoja Chief Scientific Officer
Bought
$11.40K 30,000 at 0.38
96.0%
+96% of stake
4 Mar 2026
Michael Anthony Steenberge Chief Accounting Officer
Sold on a plan
$10.63K 582 at 18.27
2.2%
Planned (10b5-1)
4 Mar 2026
Allison Swartz EVP, GC
Sold on a plan
$10.51K 599 at 17.54
0.7%
Planned (10b5-1)
4 Mar 2026
Nicholas Tatum Chief Accounting Officer
Sold on a plan 2×
$10.22K 893 at 11.45
1.5%
Planned (10b5-1)
4 Mar 2026
Patrick Fisher President, Global Limb Recon
Sold at will
$10.05K 778 at 12.92
1.5%
Not planned
4 Mar 2026
Martin Javier San Chief Medical Officer
Sold at will
$9.24K 1,720 at 5.37
9.8%
Not planned
4 Mar 2026
Andrew Cappotelli Sr Vice President Operations
Sold on a plan
$7.87K 70 at 112.48
0.4%
Planned (10b5-1)
4 Mar 2026
Walid Abi-Saab Chief Medical Officer
Sold at will
$7.32K 808 at 9.06
0.4%
Not planned
4 Mar 2026
Kevin Church Chief Scientific Officer
Sold at will
$7.30K 1,359 at 5.37
5.1%
Not planned
4 Mar 2026
Mark Worthington GENERAL COUNSEL and CCO
Sold at will
$7.13K 1,328 at 5.37
6.7%
Not planned
4 Mar 2026
Oliver Engert Chief Administrative Officer
Bought
$6.28K 250 at 25.10
0.6%
4 Mar 2026
Ali Sadri Chief Technology Officer
Sold on a plan
$5.11K 1,228 at 4.16
1.0%
Planned (10b5-1)
4 Mar 2026
Eric Rosenfeld Chief SPAC Officer
Sold at will
$4.32K 1,440,000 at 0.00
51.6%
Sold half or more
4 Mar 2026
Mark Hopman Chief Commercial Officer
Sold on a plan
$4.08K 353 at 11.57
0.3%
Planned (10b5-1)
4 Mar 2026
Edmund Dunn Principal Accounting Officer
Sold at will
$2.50K 139 at 17.96
0.6%
Not planned
4 Mar 2026
Murray Stahl President/Co-Portfolio Manager · indirect
Bought 6×
$2.23K 774 at 2.88
0.2%
Showing 14,801–14,850 of 22,712. ← Newer Page 297 of 455 Older →